[2] Cubilla AL, Wooduff JM. Primary carcinoid tumor of the breast:areport of eight patients.Am J Surg Pathol, 1977, 1 (3):283-292.
[2] Tavassoli F'A, Devile P. WHO classification of tumours, pathologyand genetics of the breast and female organs[M].lyon: IARC,2003:3234.
[3] Sapino A, Righi L, Cassoni P, et al. Exprission of apocrinedifferentiation markers inneuroendocrine breast carcinomas ofaged women[J].Mod Patho1,2001，14 (8):768-776.
[4] Maluf H M, Koemer FC. Carcinomas of the breast with endocrinedifferentiation: a review [J].Virchows Arch, 1994, 4425 (5):449457.
[5] Zekioglu O, Erhan Y, Ciris M, et al. Neuroendocrine differentiatedcarcinomas of the breast:a distinct entity[J].Breast, 2003, 12(4):251257.
[6] Stita W,Trabelsi A, Gharbi O, et al. Primary solid neuroendocrinecarcinoma of the breast[J].Can J Surg, 2009, 52 (6):1;289-1;290.
[7] 皋岚湘，丁华野.乳腺神经内分泌癌的临床病理学特点[J].临床与实验病理学杂志，2003,19 (3):236241.
[8] Shin SJ, Delellis RA, Rosen PP. Small cell carcinoma of theBreast-Additional immunohistochemical studies[J].Am J SurgPathol, 2001, 25 (6): 831832.
[9] 程少萍，韦伟.乳腺癌内分泌治疗耐药机制探讨[J].罕少疾病杂志，2010,17(1):42-46.
[10] 张晓明，范螂娣.乳腺神经内分泌癌5例临床病例分析[J].中国肿瘤临床，2005,32(13):755-758.
[11] 崔明，张霹，冷家骅，等.乳腺小细胞神经内分泌癌(附3例报告）[J].中国实用外科杂志，2008，28（7）：550-552.